LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

NCT00466258 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Diffuse Large B Cell Lymphoma

Interventions

DRUG: R-CHOP
DRUG: Highly active antiretroviral therapy
DRUG: Central nervous system (CNS) prophylaxis
DRUG: Prophylaxis of opportunistic infections and support treatment

Sponsor

PETHEMA Foundation